MiR‐506 Inhibits Multiple Targets in the Epithelial‐to‐mesenchymal Transition Network and is Associated with Good Prognosis in Epithelial Ovarian Cancer
Yan Sun,Limei Hu,Hong Zheng,Marina Bagnoli,Yuhong Guo,Rajesha Rupaimoole,Cristian Rodriguez-Aguayo,Gabriel Lopez-Berestein,Ping Ji,Kexin Chen,Anil K. Sood,Delia Mezzanzanica,Jinsong Liu,Baocun Sun,Wei Zhang
DOI: https://doi.org/10.1002/path.4443
2014-01-01
Abstract:Extensive investigations have shown that miRNAs are important regulators of epithelial‐to‐mesenchymal transition (EMT), mainly targeting the transcriptional repressors of E‐cadherin (E‐cad). Less is known about the post‐transcriptional regulation of vimentin or N‐cadherin (N‐cad) in EMT. Our previous study identified miR‐506 as a key EMT inhibitor through directly targeting the E‐cad transcriptional repressor SNAI2. In this study, we provide evidence that miR‐506 simultaneously suppresses vimentin and N‐cad. The knockdown of vimentin using siRNA reversed EMT, suppressed cell migration and invasion, and increased E‐cad expression on the cell membrane in epithelial ovarian cancer (EOC) cells. In a set of tissue microarrays that included 204 EOCs of all major subtypes (eg serous, endometrioid, clear cell, and mucinous), miR‐506 was positively correlated with E‐cad and negatively correlated with vimentin and N‐cad in all subtypes of EOC. A high level of miR‐506 was positively associated with early FIGO stage and longer survival in EOC. Introduction of miR‐506, mediated by nanoparticle delivery, in EOC orthotopic mouse models resulted in decreased vimentin, N‐cad, and SNAI2 expression and increased E‐cad expression; it also suppressed the dissemination of EOC cells. Thus, miR‐506 represents a new class of miRNA that regulates both E‐cad and vimentin/N‐cad in the suppression of EMT and metastasis. Copyright © 2014 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.